GW 841819X

CAS No. 146135-18-4

GW 841819X( GW841819X )

Catalog No. M11985 CAS No. 146135-18-4

GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GW 841819X
  • Note
    Research use only, not for human use.
  • Brief Description
    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.
  • Description
    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain that displays activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GW841819X
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    146135-18-4
  • Formula Weight
    487.94
  • Molecular Formula
    C26H22ClN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC1=CC=CC=C1)N[C@H]2C3=NN=C(C)N3C4=CC=C(OC)C=C4C(C5=CC=C(Cl)C=C5)=N2
  • Chemical Name
    (R)-benzyl (6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)carbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chung CW, et al. J Med Chem. 2011 Jun 9;54(11):3827-38. 2. Baud MG, et al. Science. 2014 Oct 31;346(6209):638-41.
molnova catalog
related products
  • Bromotriazine

    Bromotriazine (BTZ) is a covalent probe against bromodomain containing proteins.

  • GS-626510

    GS-626510 (GS-6510, GS 6510, GS 626510) is a?novel BET family bromodomains inhibitor with Kd of 0.5-2.8 nM for BRD2/3/4, and BRDT.

  • Hexamethylene bisace...

    A cell differentiation inducer that inhibits activation of NF-κB function, Akt and ERK/MAPK cascade.